I 
115TH CONGRESS 
1ST SESSION H. R. 3692 
To amend the Controlled Substances Act to provide for additional flexibility 
with respect to medication-assisted treatment for opioid use disorders, 
and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 7, 2017 
Mr. TONKO (for himself and Mr. BEN RAY LUJA´N of New Mexico) introduced 
the following bill; which was referred to the Committee on Energy and 
Commerce, and in addition to the Committee on the Judiciary, for a pe-
riod to be subsequently determined by the Speaker, in each case for con-
sideration of such provisions as fall within the jurisdiction of the com-
mittee concerned 
A BILL 
To amend the Controlled Substances Act to provide for addi-
tional flexibility with respect to medication-assisted treat-
ment for opioid use disorders, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Addiction Treatment 
Access Improvement Act of 2017’’. 
VerDate Sep 11 2014 
01:25 Sep 12, 2017
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3692.IH
H3692
rfrederick on DSKBCBPHB2PROD with BILLS
SEC. 2. ALLOWING FOR MORE FLEXIBILITY WITH RESPECT 
TO MEDICATION-ASSISTED TREATMENT FOR 
OPIOID USE DISORDERS. 
(a) CONFORMING APPLICABLE NUMBER.—Subclause 
(II) of section 303(g)(2)(B)(iii) of the Controlled Sub-
stances Act (21 U.S.C. 823(g)(2)(B)(iii)) is amended to 
read as follows: 
‘‘(II) The applicable number is— 
‘‘(aa) 100 if, not sooner than 1 year after 
the date on which the practitioner submitted 
the initial notification, the practitioner submits 
a second notification to the Secretary of the 
need and intent of the practitioner to treat up 
to 100 patients; or 
‘‘(bb) 275 if the practitioner meets the re-
quirements specified in section 8.610 of title 
42, Code of Federal Regulations (or successor 
regulations).’’. 
(b) ELIMINATING ANY TIME LIMITATION FOR NURSE 
PRACTITIONERS, CLINICAL NURSE SPECIALISTS, CER-
TIFIED REGISTERED NURSE ANESTHETISTS, CERTIFIED 
NURSE MIDWIVES, AND PHYSICIAN ASSISTANTS TO BE-
COME
QUALIFYING
PRACTITIONERS.—Section 
303(g)(2)(G)(iii)(II) of the Controlled Substances Act (21 
U.S.C. 823(g)(2)(G)(iii)(II)) is amended by striking ‘‘dur-
ing the period beginning on the date of enactment of the 
VerDate Sep 11 2014 
01:25 Sep 12, 2017
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3692.IH
H3692
rfrederick on DSKBCBPHB2PROD with BILLS
Comprehensive Addiction and Recovery Act of 2016 and 
ending on October 1, 2021’’ and inserting ‘‘beginning on 
the date of enactment of the Comprehensive Addiction and 
Recovery Act of 2016’’. 
(c) DEFINITION
OF QUALIFYING OTHER PRACTI-
TIONER.—Clause (iv) of section 303(g)(2)(G) of the Con-
trolled Substances Act (21 U.S.C. 823(g)(2)(G)) is 
amended by striking ‘‘nurse practitioner or physician as-
sistant’’ each place it appears and inserting ‘‘nurse practi-
tioner, clinical nurse specialist, certified registered nurse 
anesthetist, certified nurse midwife, or physician assist-
ant’’. 
Æ 
VerDate Sep 11 2014 
01:25 Sep 12, 2017
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H3692.IH
H3692
rfrederick on DSKBCBPHB2PROD with BILLS